DeepMed Research

VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Pragmatic Investigation of optimaL Oxygen Targets Trial

Not Applicable

Completed

Conditions: Respiratory Failure

Interventions: Other: Lower SpO2 Target
Other: Intermediate SpO2 Target
Other: Higher SpO2 Target

First Posted Date: 2018-05-25

Last Posted Date: 2023-09-25

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2541

Registration Number: NCT03537937

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension

Phase 2

Completed

Conditions: Hypertension
Lung Diseases
Estrogen Receptor Antagonist
Pulmonary Arterial Hypertension
Tamoxifen
Familial Primary Pulmonary Hypertension
Primary Pulmonary Hypertension
Hormone Antagonists
Estrogens

Interventions: Drug: Placebo Oral Tablet
Drug: Tamoxifen

First Posted Date: 2018-05-18

Last Posted Date: 2024-12-05

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 18

Registration Number: NCT03528902

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus

Phase 2

Active, not recruiting

Conditions: Lupus Erythematosus, Systemic

Interventions: Drug: Placebo
Drug: Memantine

First Posted Date: 2018-05-17

Last Posted Date: 2025-05-30

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 111

Registration Number: NCT03527472

Locations: 🇺🇸
The Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
The University of Texas Health Science Center, Houston, Houston, Texas, United States

PRecision Interventions for SMoking in the SCCS

Phase 2

Completed

Conditions: Tobacco Use Cessation

Interventions: Drug: Nicotine patch
Drug: Varenicline
Genetic: Nicotine metabolism
Genetic: Genetically-informed lung cancer risk score
Behavioral: NCI "Clearing the Air"

First Posted Date: 2018-05-11

Last Posted Date: 2020-06-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 67

Registration Number: NCT03521141

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

CPT-3 in Normal Pressure Hydrocephalus

Terminated

Conditions: Normal Pressure Hydrocephalus

First Posted Date: 2018-05-11

Last Posted Date: 2023-07-27

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 8

Registration Number: NCT03521518

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Collaborative Assessment of ICU Recovery Needs

Completed

Conditions: Post-Intensive Care Syndrome

Interventions: Other: Patient, Carer, and Clinician Interviews

First Posted Date: 2018-05-01

Last Posted Date: 2020-02-18

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 66

Registration Number: NCT03513289

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇦🇺
Australian and New Zealand Intensive Care Research Centre, Melbourne, Victoria, Australia

Comparison of Methods for Prevention of Urinary Tract Infection Following Botox Injection

Phase 4

Terminated

Conditions: Urinary Tract Infections
Overactive Bladder

Interventions: Drug: Periprocedural Antibiotics
Procedure: Injection of OnabotulinumtoxinA (BTX-A)
Drug: Extended Antibiotics

First Posted Date: 2018-04-26

Last Posted Date: 2023-11-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 22

Registration Number: NCT03508921

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

CrYobiopsy With Radial UltraSound Guidance

Not Applicable

Completed

Conditions: Pulmonary Disease

Interventions: Device: Flouroscopy
Device: Radial Endobronchial Ultrasound Probe

First Posted Date: 2018-04-24

Last Posted Date: 2019-11-12

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 10

Registration Number: NCT03506295

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Imaging Activated Macrophages in the Lungs

Phase 1

Terminated

Conditions: COPD

Interventions: Drug: Ga-EC2115

First Posted Date: 2018-04-11

Last Posted Date: 2021-08-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 13

Registration Number: NCT03494114

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Impact of Branched-Chain Amino Acid Metabolism on Limb Dysfunction in PAD

Not Applicable

Completed

Conditions: Peripheral Arterial Disease

Interventions: Behavioral: Supervised Exercise
Behavioral: Vascular Assessment

First Posted Date: 2018-04-06

Last Posted Date: 2024-02-29

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 80

Registration Number: NCT03490968

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy